Disclosure of Pregnancy-Related Privacy Risks in Clinical Research Post-Dobbs

AbstractInterventional clinical research often involves risks to participants of reproductive potential, requiring pregnancy testing, contraception, and reporting of incidental pregnancies. Since the <i>Dobbs v. Jackson Women's Health Organization</i> (2022) decision that eliminated the constitutional right to abortion, these routine research practices present new risks to participants, clinicians, and investigators. This review examines the emerging reproductive privacy concerns in clinical research post-Dobbs and provides practical considerations for investigators and institutional review boards navigating this evolving legal environment.